Christine E. Sheehan

发表

Co-downregulation of cell adhesion proteins α- and β-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas

J. Ross, C. Sheehan, B. Kallakury, 2001 .

A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma

Kai Wang, Timothy A Jennings, Doron Lipson, 2013, Clinical Cancer Research.

Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.

Prabhjot Kaur, C. Sheehan, G. Gray, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.

C. Sheehan, J S Ross, C E Sheehan, 2001, Human pathology.

A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators

C. Sheehan, Hwajeong Lee, Christine E. Sheehan, 2016, Cancer medicine.

Prognostic markers inprostate cancer

C. Sheehan, B. Kallakury, H. Fisher, 2002, Expert review of molecular diagnostics.

True synovial metaplasia of breast implant capsules: a light and electron microscopic study.

C. Sheehan, Christine E. Sheehan, A. del Rosario, 1995, Ultrastructural pathology.

PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma.

M. Mihm, C. Sheehan, H. Tsao, 2003, Journal of the American Academy of Dermatology.

Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo

L. Yin, N. Ghebranious, S. Chakraborty, 1998, Hepatology.

Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship *

C. Sheehan, M. Murphy, Christine E. Sheehan, 2004, Journal of cutaneous pathology.

Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma

P. Stephens, V. Miller, J. Suh, 2017, The American Journal of dermatopathology.

The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma

C. Sheehan, B. Kallakury, R. Kaufman, 1997, Cancer.

TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients

G. Linette, L. Cornelius, C. Sheehan, 2017, Journal of cutaneous pathology.

Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma

C. Sheehan, G. Carlson, L. Hammock, 2006, Journal of cutaneous pathology.

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Doron Lipson, Hidefumi Sasaki, Roman Yelensky, 2012, Nature Medicine.

Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non–Small Cell Lung Cancer Cells

J. Ross, C. Sheehan, U. Kasid, 2019, Molecular Cancer Research.

Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy

Kai Wang, Doron Lipson, Roman Yelensky, 2014, Modern Pathology.

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma

M. Kris, C. Azzoli, J. Ross, 2005, Cancer.

Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors.

S. Vallabhajosula, N. Bander, M. Milowsky, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survivin and Bcl-2 expression in prostatic adenocarcinomas.

J. Ross, C. Sheehan, B. Kallakury, 2009, Archives of pathology & laboratory medicine.

ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.

David M. Jones, P. Stephens, G. Frampton, 2017, The oncologist.

HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma.

R. Odze, T. Brien, C. Sheehan, 2000, Human pathology.

The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia‐associated transcription factor (MITF) and other melanogenesis‐related proteins in normal and pathological skin, hair follicles and melanocytic nevi

C. Sheehan, Christine E. Sheehan, A. Slominski, 2010, Journal of cutaneous pathology.

The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence

S. Srivastava, O. Eidelman, H. Pollard, 2013, International journal of cancer.

Prognostic factors in prostate cancer.

C. Sheehan, B. Kallakury, H. Fisher, 2003, American journal of clinical pathology.

Morphologic and Molecular Prognostic Markers in Prostate Cancer

C. Sheehan, B. Kallakury, Christine E. Sheehan, 2002, Advances in anatomic pathology.

Follicular carcinoma associated with minocycline-induced black thyroid

J. Figge, T. Jennings, Christine E. Sheehan, 1996, Endocrine pathology.

Abstract PD02-07: Next-generation sequencing of FFPE breast cancers demonstrates high concordance with FISH in callingHER2amplifications and commonly detects other clinically relevant genomic alterations

R. Yelensky, M. Cronin, M. Jarosz, 2012 .

Relapsed Classic E-Cadherin (CDH1)–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations

James X. Sun, P. Stephens, R. Yelensky, 2013, Clinical Cancer Research.

Human Cancer Biology Relapsed Classic E-Cadherin ( CDH 1 ) – Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER 2 ( ERBB 2 ) Gene Mutations

James X. Sun, P. Stephens, R. Yelensky, 2013 .

Relapsed classic E-cadherin (CDH1) mutated invasive lobular breast cancer demonstrates a high frequency of HER2 (ERBB2) gene mutations

James X. Sun, P. Stephens, R. Yelensky, 2013 .

The prognostic significance of proliferation‐associated nucleolar protein p120 expression in prostate adenocarcinoma

M. Rifkin, C. Sheehan, B. Kallakury, 1999, Cancer.

Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.

C. Sheehan, B. Kallakury, A. Haholu, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Comparison of Oncostatin M Expression in Keratoacanthoma and Squamous Cell Carcinoma

C. Sheehan, J. Carlson, Christine E. Sheehan, 2000, Modern Pathology.

Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer

P. Stephens, R. Yelensky, D. Lipson, 2014, Journal of Clinical Pathology.

New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.

David M. Jones, P. Stephens, R. Yelensky, 2014, The oncologist.

Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.

C. Sheehan, Christine E. Sheehan, T. Tran, 1997, Human pathology.

Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.

M. Rifkin, C. Sheehan, H. Fisher, 1999, The American journal of surgical pathology.

Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence.

C. Sheehan, B. Stringer, B. Kallakury, 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expression of Nuclear Factor-κB and IκBα Proteins in Prostatic Adenocarcinomas

C. Sheehan, B. Stringer, B. Kallakury, 2004, Clinical Cancer Research.

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization.

C. Sheehan, P. Muraca, H. Fisher, 1997, Human pathology.

Prognostic significance of HER‐2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinoma

J. Ross, M. Rifkin, C. Sheehan, 1997, Cancer.

Expression of Nuclear Factor- (cid:1) B and I (cid:1) B (cid:2) Proteins in Prostatic Adenocarcinomas: Correlation of Nuclear Factor- (cid:1) B Immunoreactivity with Disease Recurrence

C. Sheehan, B. Stringer, B. Kallakury, 2004 .

Myeloid cell leukemia-1 protein expression and myeloid cell leukemia-1 gene amplification in non small cell lung cancer

C. Sheehan, Christine E. Sheehan, Sungeun Kim, 2018, Indian journal of pathology & microbiology.

Comprehensive Genomic Profiling of Relapsed and Metastatic Adenoid Cystic Carcinomas by Next-generation Sequencing Reveals Potential New Routes to Targeted Therapies

P. Stephens, R. Yelensky, D. Lipson, 2014, The American journal of surgical pathology.

Decreased expression of catenins (α and β), p120 CTN, and E‐cadherin cell adhesion proteins and E‐cadherin gene promoter methylation in prostatic adenocarcinomas

E. Winn-Deen, C. Sheehan, B. Kallakury, 2001 .

Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.

E. Winn-Deen, C. Sheehan, H. Fisher, 2001, Cancer.

Her-2/neu oncogene amplification determined by fluorescence in situ hybridization.

J. Fletcher, C. Sheehan, Christine E. Sheehan, 2001, Methods in molecular medicine.

Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.

C. Sheehan, B. Kallakury, H. Fisher, 2005, Human pathology.

SERINE-910 Phosphorylated Focal Adhesion Kinase Expression Predicts Better Overall and Disease-free Survival in Melanoma

C. Sheehan, J. Carlson, S. Najjar, 2020, Applied immunohistochemistry & molecular morphology : AIMM.

Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon

Natarajan Ganesan, C. Sheehan, N. Ganesan, 2010, Cancer Cell International.

Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.

Ximing J. Yang, N. Bander, S. Geley, 2009, Human pathology.

Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.

P. Stephens, R. Yelensky, D. Lipson, 2015, Archives of pathology & laboratory medicine.

Collaborative Multi-institutional Experience in Comparing PD-L1 Immunohistochemistry Assays: Concordance of SP142 and 22C3 Immunoreactivity.

B. Kallakury, Christine E. Sheehan, J. Ross, 2018, Applied immunohistochemistry & molecular morphology : AIMM.

Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.

M. Mihm, G. Dranoff, S. Gillessen, 2000, Cancer research.

Prognostic Significance of Matrix Metalloproteinase 2 and Tissue Inhibitor of Metalloproteinase 2 Expression in Prostate Cancer

C. Sheehan, B. Kallakury, H. Fisher, 2003, Modern Pathology.

Clinical next‐generation sequencing successfully applied to fine‐needle aspirations of pulmonary and pancreatic neoplasms

P. Stephens, R. Yelensky, D. Lipson, 2013, Cancer cytopathology.

Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas.

C. Sheehan, B. Kallakury, H. Fisher, 2007, Human pathology.

319 Genomic profiling of uterine leiomyosarcomas reveal frequent alterations in Akt/mammalian target of rapamycin (mTOR) pathway genes and other actionable genomic abnormalities linked to targeted therapies

V. Miller, Siraj M. Ali, J. Elvin, 2014 .

Prognostic significance of p34cdc2 cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer.

J. Ross, Rebecca Lynn Johnson, T. Brien, 1999, American journal of clinical pathology.

PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry

David M. Jones, M. Bronner, C. Sheehan, 2017, Journal of Clinical Pathology.

Comprehensive genomic profiling of malignant phyllodes tumors of the breast

P. Stephens, S. Ganesan, V. Miller, 2017, Breast Cancer Research and Treatment.

Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies

P. Stephens, R. Yelensky, D. Lipson, 2014, Journal of Clinical Pathology.

Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.

C. Sheehan, L. Křen, J. Carlson, 2004, Annals of diagnostic pathology.

The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas.

Deepa T. Patil, C. Sheehan, Zhaohai Yang, 2018, Annals of diagnostic pathology.

HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary.

J. Ross, C. Sheehan, P. Muraca, 1999, American journal of clinical pathology.

Overexpression of WWP1 is associated with the estrogen receptor and insulin‐like growth factor receptor 1 in breast carcinoma

C. Sheehan, Zhongmei Zhou, Ceshi Chen, 2009, International journal of cancer.

Prognostic factors in gastric cancer.

J. Ross, T. Brien, C. Sheehan, 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas.

C. Sheehan, Christine E. Sheehan, W. Szyfelbein, 2001, American journal of clinical pathology.

Comparison of HER-2/ neu Oncogene Amplification Detected by Fluorescence In Situ Hybridization in Lobular and Ductal Breast Cancer

C. Sheehan, Christine E. Sheehan, P. Depowski, 2002, Applied immunohistochemistry & molecular morphology : AIMM.

The Proapoptotic Molecule BLID Interacts with Bcl-XL and Its Downregulation in Breast Cancer Correlates with Poor Disease-Free and Overall Survival

A. Noone, R. Clarke, C. Sheehan, 2010, Clinical Cancer Research.

Chapter 9.16 – Gastrointestinal Tract

C. Sheehan, A. Røseth, Christine E. Sheehan, 2013 .

E‐cadherin cell‐adhesion molecule expression as a diagnostic adjunct in urothelial cytology

J. Ross, C. Sheehan, H. Fisher, 1996, Diagnostic cytopathology.

E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder.

C. Sheehan, H. Fisher, H. Figge, 1995, Human pathology.

Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary

P. Stephens, R. Pazdur, A. Al-Hakim, 2013, Clinical Cancer Research.

Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity.

B. Arulanandam, D. Metzger, C. Sheehan, 2003, International immunopharmacology.

Dietary fish oil reduces microthrombi over atherosclerotic lesions in hyperlipidemic swine even in the absence of plasma cholesterol reduction.

J. Schmee, Christine E. Sheehan, D. N. Kim, 1993, Experimental and molecular pathology.

Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts.

Stephen F Badylak, Bhaskar Kallakury, S. Badylak, 2002, Transplant immunology.

Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts.

Terry J. Smith, C. Sheehan, P. Heldin, 2007, Endocrinology.

The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosis.

D. Prezant, R. Yucel, M. Judson, 2017, Respiratory medicine.

Melastatin expression determined by chromogenic in situ hybridization (CISH) in primary cutaneous melanoma.

G. Linette, M. Mihm, L. Cornelius, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary

P. Stephens, C. Lyssiotis, E. Shusta, 2013, Clinical Cancer Research.